|
AU1485401A
|
|
Depletion of cellular coenzyme-a levels as a means to selectively kill cancer cells
|
|
AU2196200A
|
|
Olfactory receptor expression libraries and methods of making and using them
|
|
AU3549499A
|
|
Telomerase-associated proteins
|
|
AU3187399A
|
|
Mutations in mitotic check point genes and methods of diagnosis
|
|
AU9226198A
|
|
The use of an nadph-oxidase inhibitor in the treatment of reperfusion injury
|
|
AU9376998A
|
|
Vitamin d3 analog loaded polymer formulations for cancer and neurodegenerative disorders
|
|
AU8591198A
|
|
Growth differentiation factor-15
|
|
AU8586198A
|
|
Growth differentiation factor, lefty-1
|
|
AU8399098A
|
|
Nitric oxide inhibits rhinovirus infection
|
|
AU7837898A
|
|
Method for measuring myocardial motion and the like
|
|
AU3889997A
|
|
Melanoma cell lines expressing shared immunodominant melanoma antigens nd methods of using same
|
|
AU3294097A
|
|
Pyridine derivative, composition and method for treating cancer
|
|
AU1860397A
|
|
Ebna2 peptides and methods of using same
|
|
AU6858596A
|
|
Compounds for stimulating nerve growth
|
|
AU7208494A
|
|
Controlled release of pharmaceutically active substances from coacervate microcapsules
|
